Clinical Trial Update: Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial update describes enrollment for a Quantum-Synaptic Immunotherapy approach that uses low-frequency electromagnetic resonance and ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Snippet

Sponsor: Truway Health, Inc. | Conditions: Systemic Lupus Erythematosus, Rheumatoid Arthritis | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION